$DXR 4 SEC Filings

Filed On	Filing
01 Sep 2026	Form 4: Jefferies John, Chief Medical Officer Received 2,451 shares as a grant or award
25 Jun 2026	Form 4: Michel Robert J, Chief Financial Officer Received 12,000 shares as a grant or award
25 Jun 2026	Form 4: Feldschuh Michael Richard, Director Received 30,000 shares as a grant or award
25 Jun 2026	Form 4: Feldschuh Jonathan Adam, Director Received 25,000 shares as a grant or award
25 Jun 2026	Form 4: Goudie Joy S., Director Granted 2,500 Stock Options (right to buy)
25 Jun 2026	Form 4: Cremisi Henry D., Director Granted 2,500 Stock Options (right to buy)
25 Jun 2026	Form 4: Feuer Edward, Director Granted 2,500 Stock Options (right to buy)
25 Jun 2026	Form 4: DesRosiers Caleb, Director Granted 2,500 Stock options (right to buy)
10 Apr 2026	Form 4: Feldschuh Michael Richard, Director Bought 1,000 shares ($9.07K)
31 Mar 2026	Form 4: Michel Robert J, Chief Financial Officer Bought 1,000 shares ($9.9K)
24 Mar 2026	Form 4: Jefferies John, Chief Medical Officer Bought 5,941 shares
11 Dec 2025	Form 4: Michel Robert J, Chief Financial Officer Bought 3,000 shares
11 Dec 2025	Form 4: Feldschuh Jonathan Adam, Director Bought 18,000 shares
14 Nov 2025	Form 4: Jefferies John, Chief Medical Officer Bought 2,344 shares
26 Jun 2025	Form 4: Cremisi Henry D., Director Granted 2,500 Stock Options (right to buy)
26 Jun 2025	Form 4: Feuer Edward, Director Granted 2,500 Stock Options (right to buy)
26 Jun 2025	Form 4: Goudie Joy S., Director Granted 2,500 Stock Options (right to buy)
26 Jun 2025	Form 4: DesRosiers Caleb, Director Granted 2,500 Stock options (right to buy)
07 Apr 2025	Form 4: Feldschuh Michael Richard, Director Bought 2,063 shares ($16.3K)
27 Mar 2025	Form 4: Feldschuh Michael Richard, Director Bought 1,000 shares ($8.13K)

Comments